Suppr超能文献

癌症患者放疗后的决策后悔:德国一家大型癌症中心的横断面观察研究结果。

Decision regret of cancer patients after radiotherapy: results from a cross-sectional observational study at a large tertiary cancer center in Germany.

机构信息

Department of Radiation Oncology, University Medical Center Leipzig, Stephanstr. 9a, 04103, Leipzig, Germany.

Comprehensive Cancer Center Central (CCCG) Germany, Partner Site Leipzig, Leipzig, Germany.

出版信息

J Cancer Res Clin Oncol. 2024 Mar 28;150(3):167. doi: 10.1007/s00432-024-05638-0.

Abstract

PURPOSE

The decision-making process regarding cancer treatment is emotionally challenging for patients and families, harboring the risk of decision regret. We aimed to explore prevalence and determinants of decision regret following radiotherapy.

METHODS

This cross-sectional observational study was conducted at a tertiary cancer center to assess decision regret following radiotherapy. The study employed the German version of the Ottawa Decision Regret Scale (DRS) which was validated in the study population. Decision regret was categorized as absent (0 points), mild (1-25 points), and strong (> 25 points). Various psychosocial outcome measures were collected using validated questionnaires to identify factors that may be associated with decision regret.

RESULTS

Out of 320 eligible patients, 212 participated, with 207 completing the DRS. Median age at start of radiotherapy was 64 years [interquartile range (IQR), 56-72], genders were balanced (105 female, 102 male), and the most common cancer types were breast (n = 84; 41%), prostate (n = 57; 28%), and head-and-neck cancer (n = 19; 9%). Radiotherapy was applied with curative intention in 188 patients (91%). Median time between last radiotherapy fraction and questionnaire completion was 23 months (IQR, 1-38). DRS comprehensibility was rated as good or very good by 98% (196 of 201) of patients. Decision regret was reported by 43% (n = 90) as absent, 38% (n = 78) as mild, and 18% (n = 38) as strong. In the multiple regression analysis, poor Eastern Cooperative Oncology Group performance status, low social support, and dissatisfaction with care were independent risk factors for higher decision regret after radiotherapy.

CONCLUSIONS

The German version of the DRS could be used to assess decision regret in a diverse cohort of cancer patients undergoing radiotherapy. Decision regret was prevalent in a considerable proportion of patients. Further studies are necessary to validate these findings and obtain causal factors associated with decision regret after radiotherapy.

摘要

目的

癌症治疗的决策过程对患者和家属来说具有挑战性,存在决策后悔的风险。我们旨在探讨放疗后决策后悔的发生率和决定因素。

方法

这是一项在三级癌症中心进行的横断面观察性研究,旨在评估放疗后的决策后悔。该研究采用了在研究人群中得到验证的加拿大渥太华决策后悔量表(DRS)的德文版。决策后悔分为无(0 分)、轻度(1-25 分)和强烈(>25 分)。使用经过验证的问卷收集各种社会心理结局测量指标,以确定可能与决策后悔相关的因素。

结果

在 320 名符合条件的患者中,有 212 名患者参与了研究,其中 207 名患者完成了 DRS。放疗开始时的中位年龄为 64 岁[四分位距(IQR),56-72],性别均衡(女性 105 例,男性 102 例),最常见的癌症类型为乳腺癌(n=84;41%)、前列腺癌(n=57;28%)和头颈部癌症(n=19;9%)。188 例(91%)患者接受了根治性放疗。最后一次放疗与完成问卷之间的中位时间为 23 个月(IQR,1-38)。98%(201 例中的 196 例)患者认为 DRS 易于理解或非常易于理解。43%(n=90)的患者报告无决策后悔,38%(n=78)的患者报告轻度决策后悔,18%(n=38)的患者报告强烈决策后悔。在多因素回归分析中,较差的东部肿瘤协作组表现状态、低社会支持和对治疗的不满是放疗后决策后悔的独立危险因素。

结论

加拿大渥太华决策后悔量表的德文版可用于评估接受放疗的不同癌症患者群体的决策后悔。相当一部分患者存在决策后悔。需要进一步的研究来验证这些发现,并获得与放疗后决策后悔相关的因果因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f477/10978708/d9cef1484ccc/432_2024_5638_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验